Moreover, by analysing EV-DNA, it was possible to detect three additional T790 mutant cases in patients sensitive to EGFR-TKI and two more cases in patients with acquired resistance, suggesting that liquid biopsy using EV-DNA is promising for the detection of low-rate EGFR mutations in lung cancer. This evidence concerns the gene EGFR and lung cancer.